Eton Pharmaceuticals Inc

NASDAQ:ETON   12:19:36 PM EDT
8.34
+0.61 (+7.89%)
Products, Other Pre-Announcement

Eton Pharmaceuticals Submits New Drug Application To The FDA For Topiramate Oral Solution

Published: 10/06/2020 21:42 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Submits New Drug Application to the FDA for Topiramate Oral Solution (et-101).
Eton Pharmaceuticals Inc - Product Candidate, Formerly Known As Et-101, Was Submitted for Three Indications.
Eton Pharmaceuticals Inc - Expects All Three of Neurology Product Candidates to Be Approved and Launched in 2021.